4.7 Article

Homocysteine Is Associated With Future Venous Thromboembolism in 2 Prospective Cohorts of Women

Journal

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
Volume 41, Issue 7, Pages 2215-2224

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/ATVBAHA.121.316397

Keywords

biomarker; homocysteine; plasma; pulmonary embolism; venous thromboembolism

Funding

  1. National Institutes of Health [T32 HL007575, K12 HL133117, K23 HL151871]
  2. Donald W Reynolds Foundation
  3. National Heart, Lung, and Blood Institute of the National Institutes of Health [R01HL111156]
  4. [CA047988]
  5. [HL043851]
  6. [HL080467]
  7. [HL099355]
  8. [UM1 CA182913]
  9. [HL47959]

Ask authors/readers for more resources

The study found that elevated plasma homocysteine levels are associated with VTE events in middle-aged and older women, particularly in unprovoked cases.
OBJECTIVE: Case-control studies have identified plasma homocysteine as a risk marker for venous thromboembolism (VTE). Prospective data, particularly among women, are sparse. We examined whether plasma homocysteine associates with incident VTE in 2 large prospective cohorts of women. APPROACH AND RESULTS: In the WHS (Women's Health Study), a prospective cohort study of 27 555 women >= 45 years old and free of cardiovascular disease and VTE, we assessed baseline homocysteine concentration along with other thrombotic biomarkers for association with future VTE (n=743), pulmonary embolism (n=363), and deep vein thrombosis (n=545). We used a second cohort of 2672 women (n=102 VTE events) in the WAFACS (Women's Antioxidant and Folic Acid Cardiovascular Study) to corroborate our findings. In age-adjusted analyses, elevated homocysteine, hsCRP (high-sensitivity C-reactive protein), fibrinogen, and sICAM-1 (soluble intercellular adhesion molecule-1) were associated with incident VTE (P for extreme quartile comparisons and P-trend <0.05). In multivariable models adjusting for body mass index and other traditional VTE risk factors, only the association for homocysteine persisted (HRQ4, 1.31 [95% CI, 1.06-1.63]). Elevated homocysteine levels were associated with unprovoked pulmonary embolism (HRQ4, 2.13 [95% CI, 1.30-3.51]) and deep vein thrombosis (HRQ4, 1.59 [95% CI, 1.05-2.40]) but not provoked events. In WAFACS, elevated homocysteine levels were also associated with VTE events (P-trend 0.023). CONCLUSIONS: Higher plasma homocysteine levels associate with VTE events in 2 cohorts of middle-aged and older women. Among VTE subtypes, homocysteine was associated with unprovoked, but not provoked, events. These data suggest a plausible biological role for homocysteine in the development of VTE.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available